Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/14497
標題: 犬血管肉瘤之KIT蛋白過度表現及c-kit基因缺失
KIT overexpression and a deletion in c-kit gene of canine hemangiosarcomas
作者: 陳易辰
Chen, Yi-Chen
關鍵字: c-kit基因
c-kit gene
KIT蛋白
血管肉瘤

KIT
hemangiosarcoma
canine
出版社: 獸醫學系暨研究所
引用: Akhtar, N., Padilla, M.L., Dickerson, E.B., Steinberg, H., Breen, M., Auerbach, R., Helfand, S.C., 2004. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia 6, 106-116. Al-Muhsen, S.Z., Shablovsky, G., Olivenstein, R., Mazer, B., Hamid, Q., 2004. The expression of stem cell factor and c-kit receptor in human asthmatic airways. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 34, 911-916. Amo, Y., Masuzawa, M., Hamada, Y., Katsuoka, K., 2004. Observations on angiopoietin 2 in patients with angiosarcoma. The British journal of dermatology 150, 1028-1029. Arber, D.A., Tamayo, R., Weiss, L.M., 1998. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Human pathology 29, 498-504. Arbiser, J.L., Larsson, H., Claesson-Welsh, L., Bai, X., LaMontagne, K., Weiss, S.W., Soker, S., Flynn, E., Brown, L.F., 2000. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. The American journal of pathology 156, 1469-1476. Aronsohn, M., 1985. Cardiac hemangiosarcoma in the dog: a review of 38 cases. Journal of the American Veterinary Medical Association 187, 922-926. Bastianello, S.S., 1983. A survey on neoplasia in domestic species over a 40-year period from 1935 to 1974 in the Republic of South Africa. VI. Tumours occurring in dogs. The Onderstepoort journal of veterinary research 50, 199-220. Bauer, S., Duensing, A., Demetri, G.D., Fletcher, J.A., 2007. KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway. Oncogene 26, 7560-7568. Benjamin, S.A., Lee, A.C., Angleton, G.M., Saunders, W.J., Keefe, T.J., Mallinckrodt, C.H., 1998. Mortality in beagles irradiated during prenatal and postnatal development. II. Contribution of benign and malignant neoplasia. Radiation research 150, 330-348. Besmer, P., Murphy, J.E., George, P.C., Qiu, F.H., Bergold, P.J., Lederman, L., Snyder, H.W., Jr., Brodeur, D., Zuckerman, E.E., Hardy, W.D., 1986. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320, 415-421. Bettini, G., Morini, M., Marcato, P.S., 2003. Gastrointestinal spindle cell tumours of the dog: histological and immunohistochemical study. Journal of comparative pathology 129, 283-293. Blume-Jensen, P., Claesson-Welsh, L., Siegbahn, A., Zsebo, K.M., Westermark, B., Heldin, C.H., 1991. Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. The EMBO journal 10, 4121-4128. Brisson, B.A., Holmberg, D.L., 2001. Use of pericardial patch graft reconstruction of the right atrium for treatment of hemangiosarcoma in a dog. Journal of the American Veterinary Medical Association 218, 723-725. Broudy, V.C., 1997. Stem cell factor and hematopoiesis. Blood 90, 1345-1364. Brown, L.F., Tognazzi, K., Dvorak, H.F., Harrist, T.J., 1996. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi''s sarcoma and cutaneous angiosarcoma. The American journal of pathology 148, 1065-1074. Brown, N.O., Patnaik, A.K., MacEwen, E.G., 1985. Canine hemangiosarcoma: retrospective analysis of 104 cases. Journal of the American Veterinary Medical Association 186, 56-58. Bulakowski, E.J., Philibert, J.C., Siegel, S., Clifford, C.A., Risbon, R., Zivin, K., Cronin, K.L., 2008. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006). Journal of the American Veterinary Medical Association 233, 122-128. Butnor, K.J., Burchette, J.L., Sporn, T.A., Hammar, S.P., Roggli, V.L., 2004. The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature. Archives of pathology & laboratory medicine 128, 538-543. Cairoli, R., Grillo, G., Beghini, A., Cornacchini, G., Larizza, L., Morra, E., 2004. Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis. The hematology journal : the official journal of the European Haematology Association / EHA 5, 273-275. Carpenter, J.L., Dayal, Y., King, N.W., Jr., Moore, F.M., 1991. Distinctive unclassified mesenchymal tumor of the digit of dogs. Veterinary pathology 28, 396-402. Chabot, B., Stephenson, D.A., Chapman, V.M., Besmer, P., Bernstein, A., 1988. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335, 88-89. Clifford, C.A., Hughes, D., Beal, M.W., Mackin, A.J., Henry, C.J., Shofer, F.S., Sorenmo, K.U., 2001. Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 15, 131-135. Crosier, P.S., Ricciardi, S.T., Hall, L.R., Vitas, M.R., Clark, S.C., Crosier, K.E., 1993. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82, 1151-1158. Cuccovillo, A., Lamb, C.R., 2002. Cellular features of sonographic target lesions of the liver and spleen in 21 dogs and a cat. Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 43, 275-278. Curtin, J.A., Busam, K., Pinkel, D., Bastian, B.C., 2006. Somatic activation of KIT in distinct subtypes of melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24, 4340-4346. Curtin, J.A., Fridlyand, J., Kageshita, T., Patel, H.N., Busam, K.J., Kutzner, H., Cho, K.H., Aiba, S., Brocker, E.B., LeBoit, P.E., Pinkel, D., Bastian, B.C., 2005. Distinct sets of genetic alterations in melanoma. The New England journal of medicine 353, 2135-2147. Day, M.J., Lucke, V.M., Pearson, H., 1995. A review of pathological diagnoses made from 87 canine splenic biopsies. The Journal of small animal practice 36, 426-433. De Vivo, I., Marion, M.J., Smith, S.J., Carney, W.P., Brandt-Rauf, P.W., 1994. Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride. Cancer causes & control : CCC 5, 273-278. Dernell, W.S., Withrow, S.J., Kuntz, C.A., Powers, B.E., 1998. Principles of treatment for soft tissue sarcoma. Clinical techniques in small animal practice 13, 59-64. Dervisis, N.G., Dominguez, P.A., Newman, R.G., Cadile, C.D., Kitchell, B.E., 2011. Treatment with DAV for advanced-stage hemangiosarcoma in dogs. Journal of the American Animal Hospital Association 47, 170-178. DeVinney, R., Gold, W.M., 1990. Establishment of two dog mastocytoma cell lines in continuous culture. American journal of respiratory cell and molecular biology 3, 413-420. Dickerson, E.B., Thomas, R., Fosmire, S.P., Lamerato-Kozicki, A.R., Bianco, S.R., Wojcieszyn, J.W., Breen, M., Helfand, S.C., Modiano, J.F., 2005. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma. Veterinary pathology 42, 618-632. Donaldson, R.M., Ballester, M., 1981. Cardiac masses-detection by two-dimensional echocardiography. British journal of hospital medicine 25, 596, 598-600. Dorn, C.R., Taylor, D.O., Schneider, R., Hibbard, H.H., Klauber, M.R., 1968. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 40, 307-318. Downing, S., Chien, M.B., Kass, P.H., Moore, P.E., London, C.A., 2002. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. American journal of veterinary research 63, 1718-1723. Du, C.Y., Shi, Y.Q., Zhou, Y., Fu, H., Zhao, G., 2008. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Journal of surgical oncology 98, 175-178. Duensing, A., Heinrich, M.C., Fletcher, C.D., Fletcher, J.A., 2004a. Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer investigation 22, 106-116. Duensing, A., Medeiros, F., McConarty, B., Joseph, N.E., Panigrahy, D., Singer, S., Fletcher, C.D., Demetri, G.D., Fletcher, J.A., 2004b. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 23, 3999-4006. Dunning, D., Monnet, E., Orton, E.C., Salman, M.D., 1998. Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985-1996). Journal of the American Veterinary Medical Association 212, 1276-1280. Escribano, L., Ocqueteau, M., Almeida, J., Orfao, A., San Miguel, J.F., 1998. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leukemia & lymphoma 30, 459-466. Falk, H., Herbert, J., Crowley, S., Ishak, K.G., Thomas, L.B., Popper, H., Caldwell, G.G., 1981. Epidemiology of hepatic angiosarcoma in the United States: 1964-1974. Environmental health perspectives 41, 107-113. Fosmire, S.P., Dickerson, E.B., Scott, A.M., Bianco, S.R., Pettengill, M.J., Meylemans, H., Padilla, M., Frazer-Abel, A.A., Akhtar, N., Getzy, D.M., Wojcieszyn, J., Breen, M., Helfand, S.C., Modiano, J.F., 2004. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Laboratory investigation; a journal of technical methods and pathology 84, 562-572. Frost, D., Lasota, J., Miettinen, M., 2003. Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases. Veterinary pathology 40, 42-54. Fruchter, A.M., Miller, C.W., O''Grady M, R., 1992. Echocardiographic results and clinical considerations in dogs with right atrial/auricular masses. The Canadian veterinary journal. La revue veterinaire canadienne 33, 171-174. Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K., Kanayama, Y., et al., 1993a. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92, 1736-1744. Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K., Kanayama, Y., et al., 1993b. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. The Journal of clinical investigation 92, 1736-1744. Galli, S.J., Zsebo, K.M., Geissler, E.N., 1994. The kit ligand, stem cell factor. Advances in immunology 55, 1-96. Gamlem, H., Nordstoga, K., 2008. Canine vascular neoplasia--histologic classification and inmunohistochemical analysis of 221 tumours and tumour-like lesions. APMIS. Supplementum, 19-40. Garcia, J.M., Gonzalez, R., Silva, J.M., Dominguez, G., Vegazo, I.S., Gamallo, C., Provencio, M., Espana, P., Bonilla, F., 2000. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart. British journal of cancer 82, 1183-1185. Geissler, E.N., Ryan, M.A., Housman, D.E., 1988. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55, 185-192. Gessi, M., Cattani, P., Maggiano, N., Scambia, G., Lauriola, L., Ranelletti, F.O., Ricci, R., 2002. Demonstration of human herpesvirus 8 in a case of primary vaginal epithelioid angiosarcoma by in situ hybridization, electron microscopy, and polymerase chain reaction. Diagnostic molecular pathology : the American journal of surgical pathology, part B 11, 146-151. Gibson, P.C., Cooper, K., 2002. CD117 (KIT): a diverse protein with selective applications in surgical pathology. Advances in anatomic pathology 9, 65-69. Giehl, K.A., Nagele, U., Volkenandt, M., Berking, C., 2007. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma. Journal of cutaneous pathology 34, 7-14. Gil da Costa, R.M., Matos, E., Rema, A., Lopes, C., Pires, M.A., Gartner, F., 2007. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers. BMC veterinary research 3, 19. Gingrich, D.E., Reddy, D.R., Iqbal, M.A., Singh, J., Aimone, L.D., Angeles, T.S., Albom, M., Yang, S., Ator, M.A., Meyer, S.L., Robinson, C., Ruggeri, B.A., Dionne, C.A., Vaught, J.L., Mallamo, J.P., Hudkins, R.L., 2003. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: structure-activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055. Journal of medicinal chemistry 46, 5375-5388. Graphodatsky, A.S., Kukekova, A.V., Yudkin, D.V., Trifonov, V.A., Vorobieva, N.V., Beklemisheva, V.R., Perelman, P.L., Graphodatskaya, D.A., Trut, L.N., Yang, F., Ferguson-Smith, M.A., Acland, G.M., Aguirre, G.D., 2005. The proto-oncogene C-KIT maps to canid B-chromosomes. Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology 13, 113-122. Grone, A., Weckmann, M.T., Capen, C.C., Rosol, T.J., 1996. Canine glyceraldehyde-3-phosphate dehydrogenase complementary DNA: polymerase chain reaction amplification, cloning, partial sequence analysis, and use as loading control in ribonuclease protection assays. American journal of veterinary research 57, 254-257. Gschwind, A., Fischer, O.M., Ullrich, A., 2004. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nature reviews. Cancer 4, 361-370. Hahn, K.A., Richardson, R.C., 1989. Use of cisplatin for control of metastatic malignant mesenchymoma and hypertrophic osteopathy in a dog. Journal of the American Veterinary Medical Association 195, 351-353. Halaban, R., 2000. The regulation of normal melanocyte proliferation. Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 13, 4-14. Halaban, R., Tyrrell, L., Longley, J., Yarden, Y., Rubin, J., 1993. Pigmentation and proliferation of human melanocytes and the effects of melanocyte-stimulating hormone and ultraviolet B light. Annals of the New York Academy of Sciences 680, 290-301. Hammer, A.S., Couto, C.G., Filppi, J., Getzy, D., Shank, K., 1991a. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 5, 160-166. Hammer, A.S., Couto, C.G., Swardson, C., Getzy, D., 1991b. Hemostatic abnormalities in dogs with hemangiosarcoma. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 5, 11-14. Hanks, S.K., Quinn, A.M., Hunter, T., 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42-52. Hargis, A.M., Feldman, B.F., 1991. Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988). Journal of the American Veterinary Medical Association 198, 891-894. Hargis, A.M., Ihrke, P.J., Spangler, W.L., Stannard, A.A., 1992. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Veterinary pathology 29, 316-328. Hassan, S., Kinoshita, Y., Kawanami, C., Kishi, K., Matsushima, Y., Ohashi, A., Funasaka, Y., Okada, A., Maekawa, T., He-Yao, W., Chiba, T., 1998. Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Digestive diseases and sciences 43, 8-14. Hayashi, S., Kunisada, T., Ogawa, M., Yamaguchi, K., Nishikawa, S., 1991. Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. Nucleic acids research 19, 1267-1271. Heinrich, M.C., Blanke, C.D., Druker, B.J., Corless, C.L., 2002. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20, 1692-1703. Hellstrom, S., Tengblad, A., Johansson, C., Hedlund, U., Axelsson, E., 1990. An improved technique for hyaluronan histochemistry using microwave irradiation. The Histochemical journal 22, 677-682. Hillers, K.R., Lana, S.E., Fuller, C.R., LaRue, S.M., 2007. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. Journal of the American Animal Hospital Association 43, 187-192. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Muhammad Tunio, G., Matsuzawa, Y., Kanakura, Y., Shinomura, Y., Kitamura, Y., 1998. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580. Hirsch, V.M., Jacobsen, J., Mills, J.H., 1981. A retrospective study of canine hemangiosarcoma and its association with acanthocytosis. The Canadian veterinary journal. La revue veterinaire canadienne 22, 152-155. Hollenbeck, S.T., Sakakibara, K., Faries, P.L., Workhu, B., Liu, B., Kent, K.C., 2004. Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. The Journal of surgical research 120, 288-294. Holt, D., Van Winkle, T., Schelling, C., Prymak, C., 1992. Correlation between thoracic radiographs and postmortem findings in dogs with hemangiosarcoma: 77 cases (1984-1989). Journal of the American Veterinary Medical Association 200, 1535-1539. Huizinga, J.D., Thuneberg, L., Kluppel, M., Malysz, J., Mikkelsen, H.B., Bernstein, A., 1995. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373, 347-349. Isotani, M., Ishida, N., Tominaga, M., Tamura, K., Yagihara, H., Ochi, S., Kato, R., Kobayashi, T., Fujita, M., Fujino, Y., Setoguchi, A., Ono, K., Washizu, T., Bonkobara, M., 2008. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 22, 985-988. Izquierdo, M.A., Van der Valk, P., Van Ark-Otte, J., Rubio, G., Germa-Lluch, J.R., Ueda, R., Scheper, R.J., Takahashi, T., Giaccone, G., 1995. Differential expression of the c-kit proto-oncogene in germ cell tumours. The Journal of pathology 177, 253-258. Jakab, C., Halasz, J., Kiss, A., Schaff, Z., Rusvai, M., Galfi, P., Abonyi, T.Z., Kulka, J., 2009. Claudin-5 protein is a new differential marker for histopathological differential diagnosis of canine hemangiosarcoma. Histology and histopathology 24, 801-813. Kahler, C., Didlaukat, S., Feller, A.C., Merz, H., 2007. Sensitive and reliable detection of Kit point mutation Asp 816 to Val in pathological material. Diagnostic pathology 2, 37. Kessler, M., Maurus, Y., Kostlin, R., 1997. [Hemangiosarcoma of the spleen: clinical aspects in 52 dogs]. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 25, 651-656. Kim, S.E., Liptak, J.M., Gall, T.T., Monteith, G.J., Woods, J.P., 2007. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004). Journal of the American Veterinary Medical Association 231, 1550-1557. Kim, W.Y., Kaelin, W.G., 2004. Role of VHL gene mutation in human cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, 4991-5004. Kitamura, Y., Hirotab, S., 2004. Kit as a human oncogenic tyrosine kinase. Cellular and molecular life sciences : CMLS 61, 2924-2931. Kitamura, Y., Tsujimura, T., Jippo, T., Kasugai, T., Kanakura, Y., 1995. Regulation of development, survival and neoplastic growth of mast cells through the c-kit receptor. International archives of allergy and immunology 107, 54-56. Kleine, L.J., Zook, B.C., Munson, T.O., 1970. Primary cardiac hemangiosarcomas in dogs. Journal of the American Veterinary Medical Association 157, 326-337. Kleymenova, E., Everitt, J.I., Pluta, L., Portis, M., Gnarra, J.R., Walker, C.L., 2004. Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice. Carcinogenesis 25, 309-315. Kobayashi, M., Sugisaki, O., Ishii, N., Yamada, O., Ito, K., Kuroki, S., Sasaki, Y., Ono, K., Washizu, T., Bonkobara, M., 2011. Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy. Veterinary journal. Koh, J.S., Trent, J., Chen, L., El-Naggar, A., Hunt, K., Pollock, R., Zhang, W., 2004. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histology and histopathology 19, 565-574. Komuro, T., 1999. Comparative morphology of interstitial cells of Cajal: ultrastructural characterization. Microscopy research and technique 47, 267-285. Kong, Y., Si, L., Zhu, Y., Xu, X., Corless, C.L., Flaherty, K.T., Li, L., Li, H., Sheng, X., Cui, C., Chi, Z., Li, S., Han, M., Mao, L., Lu, A., Guo, J., 2011. Large-scale analysis of KIT aberrations in Chinese patients with melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 17, 1684-1691. Kuntz, C.A., Dernell, W.S., Powers, B.E., Devitt, C., Straw, R.C., Withrow, S.J., 1997. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). Journal of the American Veterinary Medical Association 211, 1147-1151. Lamerato-Kozicki, A.R., Helm, K.M., Jubala, C.M., Cutter, G.C., Modiano, J.F., 2006. Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Experimental hematology 34, 870-878. Lasota, J., Miettinen, M., 2008. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology 53, 245-266. Lee, R.J., Springer, M.L., Blanco-Bose, W.E., Shaw, R., Ursell, P.C., Blau, H.M., 2000. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102, 898-901. Lemmon, M.A., Pinchasi, D., Zhou, M., Lax, I., Schlessinger, J., 1997. Kit receptor dimerization is driven by bivalent binding of stem cell factor. The Journal of biological chemistry 272, 6311-6317. Letard, S., Yang, Y., Hanssens, K., Palmerini, F., Leventhal, P.S., Guery, S., Moussy, A., Kinet, J.P., Hermine, O., Dubreuil, P., 2008. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Molecular cancer research : MCR 6, 1137-1145. Lev, S., Blechman, J., Nishikawa, S., Givol, D., Yarden, Y., 1993. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor. Molecular and cellular biology 13, 2224-2234. Liptak, J.M., Dernell, W.S., Ehrhart, E.J., Rizzo, S.A., Rooney, M.B., Withrow, S.J., 2004a. Retroperitoneal sarcomas in dogs: 14 cases (1992-2002). Journal of the American Veterinary Medical Association 224, 1471-1477. Liptak, J.M., Dernell, W.S., Withrow, S.J., 2004b. Haemangiosarcoma of the urinary bladder in a dog. Australian veterinary journal 82, 215-217. London, C.A., Galli, S.J., Yuuki, T., Hu, Z.Q., Helfand, S.C., Geissler, E.N., 1999. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Experimental hematology 27, 689-697. London, C.A., Kisseberth, W.C., Galli, S.J., Geissler, E.N., Helfand, S.C., 1996. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. Journal of comparative pathology 115, 399-414. London, C.A., Malpas, P.B., Wood-Follis, S.L., Boucher, J.F., Rusk, A.W., Rosenberg, M.P., Henry, C.J., Mitchener, K.L., Klein, M.K., Hintermeister, J.G., Bergman, P.J., Couto, G.C., Mauldin, G.N., Michels, G.M., 2009. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision. Clinical cancer research : an official journal of the American Association for Cancer Research 15, 3856-3865. Longley, B.J., Jr., Metcalfe, D.D., Tharp, M., Wang, X., Tyrrell, L., Lu, S.Z., Heitjan, D., Ma, Y., 1999. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proceedings of the National Academy of Sciences of the United States of America 96, 1609-1614. Longley, B.J., Jr., Morganroth, G.S., Tyrrell, L., Ding, T.G., Anderson, D.M., Williams, D.E., Halaban, R., 1993. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. The New England journal of medicine 328, 1302-1307. Longley, B.J., Reguera, M.J., Ma, Y., 2001. Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leukemia research 25, 571-576. Longley, B.J., Tyrrell, L., Lu, S.Z., Ma, Y.S., Langley, K., Ding, T.G., Duffy, T., Jacobs, P., Tang, L.H., Modlin, I., 1996. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature genetics 12, 312-314. Lux, M.L., Rubin, B.P., Biase, T.L., Chen, C.J., Maclure, T., Demetri, G., Xiao, S., Singer, S., Fletcher, C.D., Fletcher, J.A., 2000. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. The American journal of pathology 156, 791-795. Ma, G., Masuzawa, M., Hamada, Y., Haraguchi, F., Tamauchi, H., Sakurai, Y., Fujimura, T., Katsuoka, K., 2000. Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone. Journal of dermatological science 24, 126-133. Ma, Y., Longley, B.J., Wang, X., Blount, J.L., Langley, K., Caughey, G.H., 1999. Clustering of activating mutations in c-KIT''s juxtamembrane coding region in canine mast cell neoplasms. The Journal of investigative dermatology 112, 165-170. Majumder, S., Brown, K., Qiu, F.H., Besmer, P., 1988. c-kit protein, a transmembrane kinase: identification in tissues and characterization. Molecular and cellular biology 8, 4896-4903. Marino, D.J., Matthiesen, D.T., Fox, P.R., Lesser, M.B., Stamoulis, M.E., 1994. Ventricular arrhythmias in dogs undergoing splenectomy: a prospective study. Veterinary surgery : VS 23, 101-106. Martin, J., Poveda, A., Llombart-Bosch, A., Ramos, R., Lopez-Guerrero, J.A., Garcia del Muro, J., Maurel, J., Calabuig, S., Gutierrez, A., Gonzalez de Sande, J.L., Martinez, J., De Juan, A., Lainez, N., Losa, F., Alija, V., Escudero, P., Casado, A., Garcia, P., Blanco, R., Buesa, J.M., 2005. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23, 6190-6198. Mayr, B., Zwetkoff, S., Schaffner, G., Reifinger, M., 2002. Tumour suppressor gene p53 mutation in a case of haemangiosarcoma of a dog. Acta veterinaria Hungarica 50, 157-160. Meis, J.M., Enzinger, F.M., 1993. Chondroid lipoma. A unique tumor simulating liposarcoma and myxoid chondrosarcoma. The American journal of surgical pathology 17, 1103-1112. Metcalfe, D.D., 2005. Regulation of normal and neoplastic human mast cell development in mastocytosis. Transactions of the American Clinical and Climatological Association 116, 185-203; discussion 203-184. Miettinen, M., Lasota, J., 2001. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Archiv : an international journal of pathology 438, 1-12. Miettinen, M., Lasota, J., 2005. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 13, 205-220. Miettinen, M., Sarlomo-Rikala, M., Lasota, J., 2000. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 13, 536-541. Miyaki, M., 2000. [Mechanism of carcinogenesis by germline mutation of protooncogene in hereditary tumors]. Nihon rinsho. Japanese journal of clinical medicine 58, 1225-1230. Mizoguchi, M., 2004. Melanocyte development: with a message of encouragement to young women scientists. Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 17, 533-544. Morini, M., Bettini, G., Preziosi, R., Mandrioli, L., 2004. C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 52, 705-708. Morrison, W.B., DeNicola, D.B., 1993. Advantages and disadvantages of cytology and histopathology for the diagnosis of cancer. Seminars in veterinary medicine and surgery 8, 222-227. Mount, S.M., 1982. A catalogue of splice junction sequences. Nucleic acids research 10, 459-472. Murakami, A., Mori, T., Sakai, H., Murakami, M., Yanai, T., Hoshino, Y., Maruo, K., 2011. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas. Veterinary and comparative oncology 9, 219-224. Naeem, M., Dahiya, M., Clark, J.I., Creech, S.D., Alkan, S., 2002. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis. Human pathology 33, 1182-1187. Naka, N., Tomita, Y., Nakanishi, H., Araki, N., Hongyo, T., Ochi, T., Aozasa, K., 1997. Mutations of p53 tumor-suppressor gene in angiosarcoma. International journal of cancer. Journal international du cancer 71, 952-955. Nakagomi, N., Hirota, S., 2007. Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation. Laboratory investigation; a journal of technical methods and pathology 87, 365-371. Nikula, K.J., Benjamin, S.A., Angleton, G.M., Saunders, W.J., Lee, A.C., 1992. Ultraviolet radiation, solar dermatosis, and cutaneous neoplasia in beagle dogs. Radiation research 129, 11-18. Ning, Z.Q., Li, J., Arceci, R.J., 2001. Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells. Blood 97, 3559-3567. Nocka, K., Tan, J.C., Chiu, E., Chu, T.Y., Ray, P., Traktman, P., Besmer, P., 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. The EMBO journal 9, 1805-1813. Ogilvie, G.K., Powers, B.E., Mallinckrodt, C.H., Withrow, S.J., 1996. Surgery and doxorubicin in dogs with hemangiosarcoma. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 10, 379-384. Ohshima, Y., Gotoh, Y., 1987. Signals for the selection of a splice site in pre-mRNA. Computer analysis of splice junction sequences and like sequences. Journal of molecular biology 195, 247-259. Oksanen, A., 1978. Haemangiosarcoma in dogs. Journal of comparative pathology 88, 585-595. Onda, H., Lueck, A., Marks, P.W., Warren, H.B., Kwiatkowski, D.J., 1999. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. The Journal of clinical investigation 104, 687-695. Pawson, T., 2002. Regulation and targets of receptor tyrosine kinases. European journal of cancer 38 Suppl 5, S3-10. Pintar, J., Breitschwerdt, E.B., Hardie, E.M., Spaulding, K.A., 2003. Acute nontraumatic hemoabdomen in the dog: a retrospective analysis of 39 cases (1987-2001). Journal of the American Animal Hospital Association 39, 518-522. Pirie, C.G., Knollinger, A.M., Thomas, C.B., Dubielzig, R.R., 2006. Canine conjunctival hemangioma and hemangiosarcoma: a retrospective evaluation of 108 cases (1989-2004). Veterinary ophthalmology 9, 215-226. Pirkey-Ehrhart, N., Withrow, S.J.,
摘要: 犬血管肉瘤是一種源自血管內皮細胞且極具侵犯性之惡性腫瘤,具高度轉移率及造成患犬高度死亡率的特性。KIT蛋白是屬於受體型酪胺酸激酶(receptor tyrosine kinase, RTK)中第三家族的一種跨膜蛋白,,具有調節許多種類細胞內訊息傳遞的功能。KIT蛋白的過度表現在許多種人類的肉瘤及動物的腫瘤中都有被偵測到。c-kit基因的突變會導致KIT蛋白不需與幹細胞因子(stem cell factor, SCF)結合,就可自行持續磷酸化而活化啟動下游的訊息傳遞。目前犬血管肉瘤的致病因子仍不清楚。本研究的主要目的包括(一)利用免疫組織化學染色的方式去偵測KIT蛋白在犬血管瘤及血管肉瘤中的表現情形及(二)從犬血管肉瘤組織抽取腫瘤細胞的RNA後添加反轉錄酶將其反轉錄成cDNA,再利用聚合酶鏈鎖反應(polymerase chain reaction, PCR) 及TA cloning技術將c-kit基因的開放閱讀框架(open reading frame, ORF)片段增幅後定序。研究樣本包含16個犬血管瘤和24個犬血管肉瘤的組織切片以及從7個犬血管肉瘤組織的腫瘤細胞萃取而得的cDNA。結果顯示KIT蛋白在犬血管肉瘤中的陽性表現率高達83.3% (20/24),而在全部的犬血管瘤中(16/16, 100%)皆未被偵測到(χ2 = 26.667, P < 0.0001)。在本研究所有犬血管肉瘤的RNA中(7/7, 100%),其c-kit基因序列所轉譯而成之胺基酸序列中都可發現在第513至516個密碼子之間有連續四個胺基酸序列發生缺失的現象。因此KIT蛋白過度表現可以用來區別血管來源之腫瘤的良惡性,而c-kit基因的缺失在犬血管肉瘤的致病機制中扮演著何種角色值得再做更進一步的研究與探討。
Canine hemangiosarcoma (HSA) is an aggressive malignant neoplasm of vascular endothelial cell origin and is characterized by a highly metastatic rate and fatality rate. KIT (CD117) is a transmembrane protein that belongs to the type III subfamily of the receptor tyrosine kinases operating in cell signal transduction of several cell types. KIT overpression has been variably reported in some human sarcomas and domestic animal tumors. c-kit gene activating mutations typically confer constitutional KIT phosphorylation and downstream activation independent of ligand binding. The aims of this study were to investigate the expression levels of KIT protein by immunohistochemical staining, and the cDNA of the open reading frame (ORF) encoding c-kit gene amplified by polymerase chain reaction and TA cloning followed by sequencing to demonstrate the mutation of c-kit gene in canine HSAs. Forty specimens including 16 canine hemangiomas (HAs) by surgical removal, 15 canine HSAs by surgical excision and 9 cutaneous canine HSAs by needle core biopsy, either frozen or paraffin-embedded tissues, were enrolled in this study. Totally, the cDNA obtained from 7 KIT-overexpression HSAs were evaluated for c-kit ORF. Results showed that the positive immunolabelling for KIT was detected in 83.3% of (20/24) HSAs and none of HAs (16/16, 100%) demonstrated immunoactivities of KIT (Chi-square: 26.667, P < 0.0001). Diffuse cytoplasmic staining pattern of neoplastic cells were observed in all KIT positive HSAs (20/20, 100%). A deletion, named as G513-K516del, composing of four amino acids translated by codons 513-516 located in exon 9 of the c-kit gene was detected in all selected HSAs (7/7, 100%). Therefore, it was suggested that overexpression of KIT can be used to distinguish benign or malignant vascular endothelial originated tumor, and the role of a deletion in c-kit gene in the pathogenesis of canine HSAs is worthy of further investigations.
URI: http://hdl.handle.net/11455/14497
其他識別: U0005-1607201210140300
文章連結: http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0005-1607201210140300
Appears in Collections:獸醫學系所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.